AIM2 as a therapeutic target in autoimmunity: balancing inflammasome inhibition with immune homeostasis. Xu W-D, Liu Z, Su L-C, Huang A-F Autoimmun Rev. 2026 Oct 24:104218. PMID: 42925993. Abstract CommentRecommendBookmarkWatch